Infectious Diseases Clinical Research Consortium

❄️As 2023 comes to a close, the IDCRC would like to extend our gratitude to all of our members and partners for your efforts and dedication this year. We wish you and your loved ones a joyous holiday season and a happy new year! ❄️

📢Publication alert! Check out #IDCRC supported work: Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial academic.oup.com/cid/article-ab…

📰IDCRC In the News: Pedro Piedra, MD (@Baylor) was recently featured in the article, "Flu Cases Climbing as We Return to a More ‘Typical’ Season" webmd.com/cold-and-flu/n…

⬇️Check out the latest IDCRC Manual of Procedures (MOP): "IDCRC Administrative Processes" and "IDCRC Funding Procedures." MOPs describe the structure, operating policies, roles, and responsibilities of entities and individuals within the unit/consortium. idcrc.org/about/procedur…

📢Publication alert! Check out #IDCRC supported work: Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents jamanetwork.com/journals/jaman…

Congratulations to Dr Kottkamp and a great team——>Antibody Titers against Mpox Virus after Vaccination | NEJM ⁦@nyulangone⁩ ⁩ ⁦@HelpEndHIV⁩ ⁦@IDCRC_LG⁩ ⁦⁦@nyugsom_iehe⁩ ⁦@NYUGSOM_DGIMCI⁩ ⁦@NYULH_DeptofMed⁩ nejm.org/doi/full/10.10…

Highlights from the most recent grant year were presented by all VTEUs at the 2023 IDCRC Annual Meeting. This month, we're excited to feature @UMMC. Congratulations on a great year! 👏 *Note, this was created by the IDCRC LOC & is not intended to be a comprehensive list.*

Drs. Backer @DocMBacker, Mulligan @mjmull & Kottkamp @angelickott from the ID Division @NYUGSOM published their work on #COVID19vaccines 💉👏What a timely paper for this 🤧 season!!! You can read the full article here 👉 nature.com/articles/s4159… @Nature @NYUGSOM_ID @IDCRC_LG

✨IDCRC Mentee Profile: Stephanie L. Rolsma, MD, PhD, Assistant Professor, Pediatric ID, @VanderbiltU Dr. Rolsma’s current research focuses on therapeutics and interventions in critically ill patients and vaccine development through clinical trials. 🔗bit.ly/3fGCrwT

📰IDCRC In the News: Jodie Dionne (@UAB_ID) was recently featured in the article, "FDA grants approval for first time to a home test for chlamydia and gonorrhea" statnews.com/2023/11/15/chl…

📢Publication alert! Check out #IDCRC supported work: Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial science.org/doi/10.1126/sc…

✨IDCRC Spotlight: Anna Wald, MD head of the Division of Allergy & Infectious Diseases, profess. of medicine (allergy & infectious diseases), epidemiology, and laboratory medicine & pathology @UWMedicine. Wald's research focuses on #STIs incl. HSV & HPV. 🔗bit.ly/wald-profile

🎉Congrats to Carlos del Rio, @EmoryVaccineCtr VTEU PI, who was included among Georgia Trend's 500 Most Influential Leaders in Healthcare for his decades of research in infectious diseases & global health, medical education & health care administration!🔗brnw.ch/21wES9j

🍁🍂During this time of reflection, we would like to take the opportunity to thank all of our IDCRC members and partners for their unwavering commitment and dedication to our mission and work. We are grateful for everything you do and wish you a joyous and safe holiday.

📢Publication alert! Check out #IDCRC supported work: Innate immunity and interferon in SARS-CoV-2 infection outcome cell.com/immunity/fullt…

📽️JUST RELEASED: Check out our NEW #Mentoring Lecture Series video, "How to Grow a Career" presented by IDCRC's PI, Kathy Neuzil, MD (@UMMC)! youtube.com/watch?v=1N6sqx…

📢Publication alert! Check out #IDCRC supported work: Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2 academic.oup.com/aje/article-ab…

📰In the News: Igho Ofotokun, MD, MSc, professor @EmoryMedicine and LG Education & Training Committee Chair, shared the latest data that COVID-19 research team, RECOVER, has gathered on Long COVID and its symptoms during the 2023 @IDWeekmtg. Read more.⬇️ managedhealthcareexecutive.com/view/the-lates…

📢Publication alert! Check out #IDCRC supported work: NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial sciencedirect.com/science/articl…

🥳Congrats to IDCRC mentee, Lalitha Parameswaran, MD, MPH for being selected for the Robert A. Winn Diversity in Clinical Trials Career Development Award! She is one of 65 physicians taking part in this program to increase diversity in clinical trials.🔗bit.ly/3SAuCde